業績

ページタイトル画像

英文業績 2016-2020年

  • 2018年
  • 2017年
  • 2016年

2018年（Total Impact Factor 494.722）総説11件　原書・短報64件

総説

  1. Cotterill N, Madersbacher H, Wyndaele J J, Apostolidis A, Drake M J, Gajewski J, Heesakkers J, Panicker J, Radziszewski P, Sakakibara R, Sievert K D, Hamid R, Kessler T M, Emmanuel A. Neurogenic bowel dysfunction: Clinical management recommendations of the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013. Neurourol Urodyn.2018;37(1):46-53.
  2. Hashimoto M, Ho G, Shimizu Y, Sugama S, Takenouchi T, Waragai M, Wei J, Takamatsu Y. Potential Application of Centrifuges to Protect the CNS in Space and on Earth. Curr Alzheimer Res.2018;15(6):544-551.
  3. Koga S, Dickson D. W. Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy. J Neurol Neurosurg Psychiatry.2018;89(2):175-184.
  4. Mori M, Kuwabara S, Paul F. Worldwide prevalence of neuromyelitis optica spectrum disorders. J Neurol Neurosurg Psychiatry. 2018;89(6):555-556.
  5. Sakakibara R. Cyclic vomiting syndrome: the nervous system has the guts. Clin Auton Res. 2018;28(2):167-169.
  6. Sakakibara R, Tateno F, Yamamoto T, Uchiyama T, Yamanishi T. Urological dysfunction in synucleinopathies: epidemiology, pathophysiology and management. Clin Auton Res. 2018;28(1):83-101.
  7. Sekijima Y, Ueda M, Koike H, Misawa S, Ishii T, Ando Y. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Orphanet J Rare Dis. 2018;13(1):6.
  8. Takamatsu Y, Fujita M, Ho G J, Wada R, Sugama S, Takenouchi T, Waragai M, Masliah E, Hashimoto M. Motor and Nonmotor Symptoms of Parkinson's Disease: Antagonistic Pleiotropy Phenomena Derived from α-Synuclein Evolvability? Parkinsons Dis. 2018:5789424. eCollection 2018.
  9. Uncini A, Kuwabara S. The electrodiagnosis of Guillain-Barré syndrome subtypes: Where do we stand? Clin Neurophysiol. 2018;129(12):2586-2593.
  10. Uzawa A, Mori M, Kuwabara S. MOG antibody disorders and AQP4 antibody NMO spectrum disorders share a common immunopathogenesis. J Neurol Neurosurg Psychiatry. 2018;89(9):900.
  11. Waragai M, Ho G, Takamatsu Y, Shimizu Y, Sugino H, Sugama S, Takenouchi T, Masliah E, Hashimoto M. Dual-therapy strategy for modification of adiponectin receptor signaling in aging-associated chronic diseases. Drug Discov Today. 2018;23(6):1305-1311.

原著・短報

  1. Agarwal S, Highton-Williamson E, Caga J, Matamala J M, Dharmadasa T, Howells J, Zoing M C, Shibuya K, Geevasinga N, Vucic S, Hodges J R, Ahmed R M, Kiernan M C. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum. J Neurol. 2018;265(8):1819-1828.
  2. Allen M, Wang X, Serie DJ, Strickland SL, Burgess JD, Koga S, Younkin CS, Nguyen TT, Malphrus KG, Lincoln SJ, Alamprese M, Zhu K, Chang R, Carrasquillo MM, Kouri N, Murray ME, Reddy JS, Funk C, Price ND, Golde TE, Younkin SG, Asmann YW, Crook JE, Dickson DW, Ertekin-Taner N. Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy. Acta Neuropathol. 2018;136(5):709-727.
  3. Aoyama S, Mori M, Uzawa A, Uchida T, Masuda H, Ohtani R, Kuwabara S. Serum anti-JCV antibody indexes in Japanese patients with multiple sclerosis: elevations along with fingolimod treatment duration. J Neurol. 2018;265(5):1145-1150.
  4. Aoyama S, Mori M, Uzawa A, Uchida T, Masuda H, Ohtani R, Kuwabara S. Serum anti-John Cunningham virus antibody seroprevalence and index among Japanese patients with neuromyelitis optica spectrum disorders. Mult Scler J. 2018:1352458518808473.
  5. Borisow N, Mori M, Kuwabara S, Scheel M, Paul F. Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis. Front Neurol. 2018;9:888.
  6. Chiotis K, Stenkrona P, Almkvist O, Stepanov V, Ferreira D, Arakawa R, Takano A, Westman E, Varrone A, Okamura N, Shimada H, Higuchi M, Halldin C, Nordberg A. Dual tracer tau PET imaging reveals different molecular targets for (11)C-THK5351 and (11)C-PBB3 in the Alzheimer brain. Eur J Nucl Med Mol Imaging. 2018;45(9):1605-1617.
  7. Doets AY, Verboon C, van den Berg B, Harbo T, Cornblath DR, Willison HJ, Islam Z, Attarian S, Barroso FA, Bateman K, Benedetti L, van den Bergh P, Casasnovas C, Cavaletti G, Chavada G, Claeys KG, Dardiotis E, Davidson A, van Doorn PA, Feasby TE, Galassi G, Gorson KC, Hartung HP, Hsieh ST, Hughes RAC, Illa I, Islam B, Kusunoki S, Kuwabara S, Lehmann HC, Miller JAL, Mohammad QD, Monges S, Nobile Orazio E, Pardo J, Pereon Y, Rinaldi S, Querol L, Reddel SW, Reisin RC, Shahrizaila N, Sindrup SH, Waqar W, Jacobs BC; IGOS Consortium. Regional variation of Guillain-Barré syndrome. Brain. 2018;141(10):2866-2877.
  8. Endo H, Sekiguchi K, Shimada H, Ueda T, Kowa H, Kanda F, Toda T. Low signal intensity in motor cortex on susceptibility-weighted MR imaging is correlated with clinical signs of amyotrophic lateral sclerosis: a pilot study. J Neurol. 2018;265(3):552-561.
  9. Gajewski J B, Schurch B, Hamid R, Averbeck M, Sakakibara R, Agro E F, Dickinson T, Payne C K, Drake M J ,Haylen B T. An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD). Neurourol Urodyn. 2018;37(3):1152-1161.
  10. Hashimoto M, Ho G, Sugama S, Takamatsu Y, Shimizu Y, Takenouchi T, Waragai M, Masliah E. Evolvability of Amyloidogenic Proteins in Human Brain. J Alzheimers Dis. 2018;62(1):73-83.
  11. Hashimoto M, Ho G, Takamatsu Y, Shimizu Y, Sugama S, Takenouchi T, Waragai M, Masliah E. Evolvability and Neurodegenerative Disease: Antagonistic Pleiotropy Phenomena Derived from Amyloid Aggregates. J Parkinsons Dis. 2018;8(3):405-408.
  12. Hashimoto M, Ho G, Takamatsu Y, Wada R, Sugama S, Takenouchi T, Masliah E, Waragai M. Possible Role of the Polyglutamine Elongation in Evolution of Amyloid-Related Evolvability. J Huntingtons Dis. 2018;7(4):297-307.
  13. Hayashi Y, Miura G, Uzawa A, Baba T, Yamamoto S. Case of convulsive seizure developing during electroretinographic recordings: a case report. BMC Neurol. 2018;18(1):52.
  14. Hiraga A, Aoki R, Morooka M, Kano H, Kuwabara S. Isolated iliopsoas paresis due to traumatic cortical hemorrhage. Neurol Sci. 2018;39(7):1297-1298.
  15. Hiraga A, Aoki R, Nakamura K, Kuwabara S. Rapidly progressive Aspergillus meningitis successfully treated with voriconazole and corticosteroids. Neurol Sci. 2018;39(3):577-579.
  16. Hiraga A, Kuwabara S. Meningitis-retention syndrome: Clinical features, frequency and prognosis. J Neurol Sci. 2018;390:261-264.
  17. Hirano S, Shinotoh H, Shimada H, Ota T, Sato K, Tanaka N, Zhang M R, Higuchi M, Fukushi K, Irie T, Kuwabara S, Suhara T. Voxel-Based Acetylcholinesterase PET Study in Early and Late Onset Alzheimer's Disease. J Alzheimers Dis. 2018;62(4):1539-1548.
  18. Imai T, Utsugisawa K, Murai H, Tsuda E, Nagane Y, Suzuki Y, Minami N, Uzawa A, Kawaguchi N, Masuda M, Konno S, Suzuki H, Akaishi T, Aoki M. Oral corticosteroid dosing regimen and long-term prognosis in generalised myasthenia gravis: a multicentre cross-sectional study in Japan. J Neurol Neurosurg Psychiatry. 2018;89(5):513-517.
  19. Ishikawa A, Tokunaga M, Maeda J, Minamihisamatsu T, Shimojo M, Takuwa H, Ono M, Ni R, Hirano S, Kuwabara S, Ji B, Zhang M. R, Aoki I, Suhara T, Higuchi M, Sahara N. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510. J Alzheimers Dis. 2018;61(3):1037-1052.
  20. Kasanuki K, Josephs KA, Ferman TJ, Murray ME, Koga S, Konno T, Sakae N, Parks A, Uitti RJ, Van Gerpen JA, Graff-Radford NR, Wszolek ZK, Dickson DW. Diffuse Lewy body disease manifesting as corticobasal syndrome: A rare form of Lewy body disease. Neurology. 2018;91(3):e268-e79.
  21. Kasanuki K, Ross O. A, DeTure M. A, Walton R. L, Sanchez-Contreras M, Koga S, Murray M. E, Rademakers R, Dickson D. W. Relationships between lewy and tau pathologies in 375 consecutive non-Alzheimer's olfactory bulbs. Mov Disord. 2018;33(2):333-334.
  22. Kawaguchi N, Nakatani K, Uzawa A, Nemoto Y, Himuro K, Kuwabara S. Polymorphisms of CYP3A5 Affect Serum Levels and Maintenance Doses of Tacrolimus in Myasthenia Gravis Patients. Journal of Pharmacovigilance. 2018;6(2):1000258.
  23. Gudesblatt M, Guillaume D, Haas J, Hancinova V, Hancu A, Hardiman O, Harmjanz A, Heidenreich FR, Hengstman GJD, Herbert J, Herring M, Hodgkinson S, Hoffmann OM, Hofmann WE, Honeycutt WD, Hua LH, Huang D, Huang Y, Huang D, Hupperts R, Imre P, Jacobs AK, Jakab G, Jasinska E, Kaida K, Kalnina J, Kaprelyan A, Karelis G, Karussis D, Katz A, Khabirov FA, Khatri B, Kimura T, Kister I, Kizlaitiene R, Klimova E, Koehler J, Komatineni A, Kornhuber A, Kovacs K, Koves A, Kozubski W, Krastev G, Krupp LB, Kurca E, Lassek C, Laureys G, Lee L, Lensch E, Leutmezer F, Li H, Linker RA, Linnebank M, Liskova P, Llanera C, Lu J, Lutterotti A, Lycke J, Macdonell R, Maciejowski M, Maeurer M, Magzhanov RV, Maida EM, Malciene L, Mao-Draayer Y, Marfia GA, Markowitz C, Mastorodimos V, Matyas K, Meca-Lallana J, Merino JAG, Mihetiu IG, Milanov I, Miller AE, Millers A, Mirabella M, Mizuno M, Montalban X, Montoya L, Mori M, Mueller S, Nakahara J, Nakatsuji Y, Newsome S, Nicholas R, Nielsen AS, Nikfekr E, Nocentini U, Nohara C, Nomura K, Odinak MM, Olsson T, van Oosten BW, Oreja-Guevara C, Oschmann P, Overell J, Pachner A, Panczel G, Pandolfo M, Papeix C, Patrucco L, Pelletier J, Piedrabuena R, Pless M, Polzer U, Pozsegovits K, Rastenyte D, Rauer S, Reifschneider G, Rey R, Rizvi SA, Robertson D, Rodriguez JM, Rog D, Roshanisefat H, Rowe V, Rozsa C, Rubin S, Rusek S, Saccà F, Saida T, Salgado AV, Sanchez VEF, Sanders K, Satori M, Sazonov DV, Scarpini EA, Schlegel E, Schluep M, Schmidt S, Scholz E, Schrijver HM, Schwab M, Schwartz R, Scott J, Selmaj K, Shafer S, Sharrack B, Shchukin IA, Shimizu Y, Shotekov P, Siever A, Sigel KO, Silliman S, Simo M, Simu M, Sinay V, Siquier AE, Siva A, Skoda O, Solomon A, Stangel M, Stefoski D, Steingo B, Stolyarov ID, Stourac P, Strassburger-Krogias K, Strauss E, Stuve O, Tarnev I, Tavernarakis A, Tello CR, Terzi M, Ticha V, Ticmeanu M, Tiel-Wilck K, Toomsoo T, Tubridy N, Tullman MJ, Tumani H, Turcani P, Turner B, Uccelli A, Urtaza FJO, Vachova M, Valikovics A, Walter S, Van Wijmeersch B, Vanopdenbosch L, Weber JR, Weiss S, Weissert R, Vermersch P, West T, Wiendl H, Wiertlewski S, Wildemann B, Willekens B, Visser LH, Vorobeychik G, Xu X, Yamamura T, Yang YN, Yelamos SM, Yeung M, Zacharias A, Zelkowitz M, Zettl U, Zhang M, Zhou H, Zieman U, Ziemssen T. Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study. Lancet. 2018;391(10127):1263-1273.
  24. Kawajiri-Manako, Mimura N, Fukuyo M, Namba H, Rahmutulla B, Nagao Y, Togasaki E, Shimizu R, Oshima-Hasegawa N, Tsukamoto S, Mitsukawa S, Takeda Y, Ohwada C, Takeuchi M, Iseki T, Misawa S, Yokote K, Tsuiji M, Kuwabara S, Sakaida E, Kaneda A, Nakaseko C. Clonal immunoglobulin λ light-chain gene rearrangements detected by next generation sequencing in POEMS syndrome. Am J Hematol. 2018;93(9):1161-1168.
  25. Kitamura S, Shimada H, Niwa F, Endo H, Shinotoh H, Takahata K, Kubota M, Takado Y, Hirano S, Kimura Y, Zhang MR, Kuwabara S, Suhara T, Higuchi M. Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2018;89(11):1208-1214.
  26. Koga S, Lin W L, Walton R L, Ross O A Dickson D. W. TDP-43 pathology in multiple system atrophy: colocalization of TDP-43 and alpha-synuclein in glial cytoplasmic inclusions. Neuropathol Appl Neurobiol. 2018;44(7):707-721.
  27. Koga S, Kouri N, Walton RL, Ebbert MTW, Josephs KA, Litvan I, Graff-Radford N, Ahlskog JE, Uitti RJ, van Gerpen JA, Boeve BF, Parks A, Ross OA, Dickson DW. Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype. Acta Neuropathol. 2018;136(3):389-404.
  28. Koh K, Ishiura H, Beppu M, Shimazaki H, Ichinose Y, Mitsui J, Kuwabara S, Tsuji S, Takiyama Y; Japan Spastic Paraplegia Research Consortium. Novel mutations in the ALDH18A1 gene in complicated hereditary spastic paraplegia with cerebellar ataxia and cognitive impairment. J Hum Genet. 2018;63(9):1009-1013.
  29. Kuwabara S. B-7. Electrodiagnostic criteria for ALD: Current state and perspectives. Clinical Neurophysiology. 2018;129(5):e19.
  30. Kuwabara S, Misawa S, Mori M, Iwai Y, Ochi K, Suzuki H, Nodera H, Tamaoka A, Iijima M, Toda T, Yoshikawa H, Kanda T, Sakamoto K, Kusunoki S, Sobue G, Kaji R. Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi-center, open-label, 52-week phase 3 trial. J Peripher Nerv Syst. 2018;23(2):115-119.
  31. Liesinger AM, Graff-Radford NR, Duara R, Carter RE, Hanna Al-Shaikh FS, Koga S, Hinkle KM, DiLello SK, Johnson MF, Aziz A, Ertekin-Taner N, Ross OA, Dickson DW, Murray ME. Sex and age interact to determine clinicopathologic differences in Alzheimer's disease. Acta Neuropathol. 2018;136(6):873-885.
  32. Makino T, Sugano I, Kamitsukasaa I. An Autopsy Case of Edwardsiella tarda Meningoencephalitis. Case Rep Neurol. 2018;10(2):252-260.
  33. Masuda H, Mori M, Umehara K, Furihata T, Uchida T, Uzawa A, Kuwabara S. Soluble CD40 ligand disrupts the blood-brain barrier and exacerbates inflammation in experimental autoimmune encephalomyelitis. J Neuroimmunol. 2018;316:117-120.
  34. Masuda H, Mori M, Uzawa A, Uchida T, Ohtani R, Kobayashi S, Kuwabara S. Validation of the Modified Fatigue Impact Scale and the relationships among fatigue, pain and serum interleukin-6 levels in patients with neuromyelitis optica spectrum disorder. J Neurol Sci. 2018;385:64-68.
  35. Matsuda H, Murata M, Mukai Y, Sako K, Ono H, Toyama H, Inui Y, Taki Y, Shimomura H, Nagayama H, Tateno A, Ono K, Murakami H, Kono A, Hirano S, Kuwabara S, Maikusa N, Ogawa M, Imabayashi E, Sato N, Takano H, Hatazawa J, Takahashi R. Japanese multicenter database of healthy controls for [(123)I]FP-CIT SPECT. Eur J Nucl Med Mol Imaging.2018;45(8):1405-1416.
  36. Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida K I, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R,  Kusunoki S. Safety and efficacy of eculizumab in Guillain-Barre syndrome: a multicentre, double-blind, randomised phase 2 trial. Lancet Neurol.2018;17(6):519-529.
  37. Nakamura K, Yamanaka Y, Higuchi Y, Hirano S, Kuroiwa R, Abe M, Murata A, Iwadate Y, Kuwabara S, Yamamoto T. Improved self-perceived performance for continence problems in patients with Parkinson’s disease after deep brain stimulation. Neurology and Clinical Neuroscience. 2018:1-6.
  38. Noto Y, Garg N, Li T, Timmins HC, Park SB, Shibuya K, Shahrizaila N, Huynh W, Matamala JM, Dharmadasa T, Yiannikas C, Vucic S, Kiernan MC. Comparison of cross-sectional area and distal-proximal nerve ratios in amyotrophic lateral sclerosis. Muscle Nerve. 2018;58(6):777-783.
  39. Noto Y I, Simon N G, Selby A, Garg N, Shibuya K, Shahrizaila N, Huynh W, Matamala J M, Dharmadasa T, Park S B, Vucic S, Kiernan M C. Ectopic impulse generation in peripheral nerve hyperexcitability syndromes and amyotrophic lateral sclerosis. Clin Neurophysiol. 2018;129(5):974-980.
  40. Ohtani R, Mori M, Uchida T, Uzawa A, Masuda H, Liu J Kuwabara S. Risk factors for fingolimod-induced lymphopenia in multiple sclerosis. Mult Scler J Exp Transl Clin. 2018; 4(1):2055217318759692.
  41. Ohwada C, Sakaida E, Kawajiri-Manako C, Nagao Y, Oshima-Hasegawa N, Togasaki E, Muto T, Tsukamoto S, Mitsukawa S, Takeda Y, Mimura N, Takeuchi M, Shimizu N, Misawa S, Iseki T, Kuwabara S, Nakaseko C. Long-term evaluation of physical improvement and survival of autologous stem cell transplantation in POEMS syndrome. Blood. 2018;131(19):2173-2176.
  42. Ogaki K, Heckman MG, Koga S, Martens YA, Labbé C, Lorenzo-Betancor O, Walton RL, Soto AI, Vargas ER, Fujioka S, Uitti RJ, van Gerpen JA, Cheshire WP, Younkin SG, Wszolek ZK, Low PA, Singer W, Bu G, Dickson DW, Ross OA. Association study between multiple system atrophy and TREM2 p.R47H. Neurol Genet. 2018;4(4):e257.
  43. Ogaki K, Martens Y. A, Heckman M. G, Koga S, Labbe C, Lorenzo-Betancor O, Wernick A. I, Walton R. L, Soto A. I, Vargas E. R, Nielsen H. M, Fujioka S, Kanekiyo T, Uitti R. J, van Gerpen J. A, Cheshire W. P, Wszolek Z. K, Low P. A, Singer W, Dickson D. W, Bu G, Ross O. A. Multiple system atrophy and apolipoprotein E. Mov Disord. 2018;33(4):647-650.
  44. Sakakibara R, Lee FC, Suzuki H, Tateno F, Kishi M, Aiba Y. Parkinson's disease and prostate enlargement: Both contribute to overactive bladder in the elderly. Int J Urol. 2018;25(11):982-983.
  45. Sakakibara R, Shimizu A, Takahashi O, Tateno F, Kishi M, Aiba Y, Suzuki H, Yamamoto T, Shibata C, Yamanishi T. Lower Urinary Tract Function in Familial Spastic Paraplegia. Eur Neurol. 2018;80(3-4):121-125.
  46. Sakakibara R, Takahashi O, Nishimura H, Tateno F, Kishi M, Tsuyusaki Y, Aiba Y, Tatsuno I. The Relationship between Bladder, Periarterial and Somatic Neuropathy in Diabetes. Intern Med. 2018;57(15):2165-2168.
  47. Sakakibara R, Tateno F, Aiba Y, Ogata T, Kishi M, Terada H, Inaoka T, Nakatsuka T, Matsuoka K. MIBG Myocardial Scintigraphy Identifies Premotor PD/DLB During a Negative DAT Scan Period: Second Report. Mov Disord Clin Pract. 2018;6(1):46-50.
  48. Sawada D, Fujii K, Misawa S, Shiohama T, Fukuhara T, Fujita M, Kuwabara S, Shimojo N. Bilateral spinal anterior horn lesions in acute motor axonal neuropathy. Brain Dev. 2018;40(9):830-832.
  49. Sugimoto K, Hiwasa T, Shibuya K, Hirano S, Beppu M, Isose S, Arai K, Takiguchi M, Kuwabara S, Mori M. Novel autoantibodies against the proteasome subunit PSMA7 in amyotrophic lateral sclerosis. J Neuroimmunol. 2018;325:54-60.
  50. Sugiyama A, Beppu M, Kuwabara S. Teaching NeuroImages: Cerebral cortex swelling in Creutzfeldt-Jakob disease with V180I mutation. Neurology. 2018;91(2):e185-e6.
  51. Sugiyama A, Sato N, Kimura Y, Ota M, Maekawa T, Sone D, Enokizono M, Murata M, Matsuda H, Kuwabara S. MR findings in the substantia nigra on phase difference enhanced imaging in neurodegenerative parkinsonism. Parkinsonism Relat Disord. 2018;48:10-16.
  52. Sugiyama A, Sato N, Nakata Y, Kimura Y, Enokizono M, Maekawa T, Kondo M, Takahashi Y, Kuwabara S, Matsuda H. Clinical and magnetic resonance imaging features of elderly onset dentatorubral-pallidoluysian atrophy. J Neurol. 2018;265(2):322-329.
  53. Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Suzuki S, Haruyama Y, Kobashi G, Hirata K. The prevalence, course and clinical correlates of migraine in Parkinson's disease: A multicentre case-controlled study. Cephalalgia. 2018;38(9):1535-1544.
  54. Takenoshita N, Fukasawa R, Ogawa Y, Shimizu S, Umahara T, Ishii K, Shimada H, Higuchi M, Suhara T, Hanyu H. Amyloid and tau positron emission tomography in suggested diabetes-related dementia. Curr Alzheimer Res. 2018;15(11):1062-1069.
  55. Tanaka TD, Misawa S, Yoshimura M, Kuwabara S. Reversal of pulmonary arterial hypertension in POEMS syndrome with thalidomide: a case report. Eur Heart J Case Rep. 2018;2(2):yty051.
  56. Tohnai G, Nakamura R, Sone J, Nakatochi M, Yokoi D, Katsuno M, Watanabe H, Watanabe H, Ito M, Li Y, Izumi Y, Morita M, Taniguchi A, Kano O, Oda M, Kuwabara S, Abe K, Aiba I, Okamoto K, Mizoguchi K, Hasegawa K, Aoki M, Hattori N, Onodera O, Naruse H, Mitsui J, Takahashi Y, Goto J, Ishiura H, Morishita S, Yoshimura J, Doi K, Tsuji S, Nakashima K, Kaji R, Atsuta N, Sobue G. Frequency and characteristics of the TBK1 gene variants in Japanese patients with sporadic amyotrophic lateral sclerosis. Neurobiol Aging. 2018;64:158.e15-158.
  57. Uzawa A, Furuya T, Ohtori S, Kuwabara S. Spinal myoclonus selectively affecting the platysma after cervical laminectomy. Neurology. 2018;91(1):45-46.
  58. Uzawa A, Mori M, Masuda H, Ohtani R, Uchida T, Kuwabara S. Recombinant thrombomodulin ameliorates experimental autoimmune encephalomyelitis by suppressing high mobility group box 1 and inflammatory cytokines. Clin Exp Immunol. 2018;193(1):47-54.
  59. van Schaik I. N, Bril V, van Geloven N, Hartung H. P, Lewis R. A, Sobue G, Lawo J. P, Praus M, Mielke O, Durn B. L, Cornblath D. R. Merkies I. S. J. Sabet A, George K, Roberts L, Carne R, Blum S, Henderson R, Van Damme P, Demeestere J, Larue S, D'Amour C, Bril V, Breiner A, Kunc P, Valis M, Sussova J, Kalous T, Talab R, Bednar M, Toomsoo T, Rubanovits I, Gross-Paju K, Sorro U, Saarela M, Auranen M, Pouget J, Attarian S, Le Masson G, Wielanek-Bachelet A, Desnuelle C, Delmont E, Clavelou P, Aufauvre D, Schmidt J, Zschuentssch J, Sommer C, Kramer D, Hoffmann O, Goerlitz C, Haas J, Chatzopoulos M, Yoon R, Gold R, Berlit P, Jaspert-Grehl A, Liebetanz D, Kutschenko A, Stangel M, Trebst C, Baum P, Bergh F, Klehmet J, Meisel A, Klostermann F, Oechtering J, Lehmann H, Schroeter M, Hagenacker T, Mueller D, Sperfeld A, Bethke F, Drory V, Algom A, Yarnitsky D, Murinson B, Di Muzio A, Ciccocioppo F, Sorbi S, Mata S, Schenone A, Grandis M, Lauria G, Cazzato D, Antonini G, Morino S, Cocito D, Zibetti M, Yokota T, Ohkubo T, Kanda T, Kawai M, Kaida K, Onoue H, Kuwabara S, Mori M, Iijima M, Ohyama K, Baba M, Tomiyama M, Nishiyama K, Akutsu T, Yokoyama K, Kanai K, van Schaik IN, Eftimov F, Notermans NC, Visser N, Faber C, Hoeijmakers J, Rejdak K, Chyrchel-Paszkiewicz U, Casanovas Pons C, Alberti Aguiló M, Gamez J, Figueras M, Marquez Infante C, Benitez Rivero S, Lunn M, Morrow J, Gosal D, Lavin T, Melamed I, Testori A, Ajroud-Driss S, Menichella D, Simpson E, Chi-Ho Lai E, Dimachkie M, Barohn RJ, Beydoun S, Johl H, Lange D, Shtilbans A, Muley S, Ladha S, Freimer M, Kissel J, Latov N, Chin R, Ubogu E, Mumfrey S, Rao T, MacDonald P, Sharma K, Gonzalez G, Allen J, Walk D, Hobson-Webb L, Gable K. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Neurol. 2018;17(1):35-46.
  60. van Schaik IN, Mielke O; PATH study group. Sabet A, George K, Roberts L, Carne R, Blum S, Henderson R, Van Damme P, Demeestere J, Larue S, Pinard D'Amour CA, Bril V, Breiner A, Kunc P, Valis M, Sussova J, Kalous T, Talab R, Bednar M, Toomsoo T, Rubanovits I, Gross-Paju K, Sorro U, Saarela M, Auranen M, Pouget J, Attarian S, Le Masson G, Wielanek-Bachelet AC, Desnuelle C, Delmont E, Clavelou P, Aufauvre D, Schmidt J, Zschuentssch J, Sommer C, Kramer D, Hoffmann O, Goerlitz C, Haas J, Chatzopoulos M, Yoon MS, Gold R, Berlit P, Jaspert-Grehl A, Liebetanz D, Kutschenko A, Stangel M, Trebst C, Baum P, Then Bergh F, Klehmet J, Meisel A, Klostermann F, Oechtering J, Lehmann H, Schroeter M, Hagenacker T, Mueller D, Sperfeld AD, Bethke F, Hartung HP, Drory V, Algom A, Yarnitsky D, Murinson BB, Di Muzio A, Ciccocioppo F, Sorbi S, Mata S, Schenone A, Grandis M, Lauria G, Cazzato D, Antonini G, Morino S, Cocito D, Zibetti M, Yokota T, Ohkubo T, Kanda T, Kawai M, Kaida K, Onoue H, Kuwabara S, Mori M, Iijima M, Ohyama K, Sobue G, Baba M, Tomiyama M, Nishiyama K, Akutsu T, Yokoyama K, Kanai K, van Schaik IN, Eftimov F, Notermans NC, Visser NA, Faber C, Hoeijmakers JGJ, Merkies ISJ, van Geloven N, Rejdak K, Chyrchel-Paszkiewicz U, Casanovas Pons C, Alberti Aguiló MA, Gamez J, Figueras M, Marquez Infante C, Benitez Rivero S, Lunn M, Morrow J, Gosal D, Lavin TM, Melamed I, Testori A, Ajroud-Driss S, Menichella D, Simpson E, Chi-Ho Lai E, Dimachkie M, Barohn RJ, Beydoun S, Johl H, Lange D, Shtilbans A, Muley S, Ladha S, Freimer M, Kissel J, Latov N, Chin R, Ubogu E, Mumfrey S, Rao THP, MacDonald P, Sharma K, Gonzalez G, Allen J, Walk D, Hobson-Webb L, Gable K, Lewis RA, Cornblath DR, Lawo JP, Praus M, Durn BL, Mielke O. Intravenous versus subcutaneous immunoglobulin - Authors' reply. Lancet Neurol. 2018;17(5):393-394.
  61. Watanabe K, Hirano S, Kojima K, Nagashima K, Mukai H, Sato T, Takemoto M, Matsumoto K, Iimori T, Isose S, Omori S, Shibuya K, Sekiguchi Y, Beppu M, Amino H, Suichi T, Yokote K, Uno T, Kuwabara S, Misawa S. Altered cerebral blood flow in the anterior cingulate cortex is associated with neuropathic pain. J Neurol Neurosurg Psychiatry. 2018;89(10):1082-1087.
  62. Yoshida K, Kuwabara S, Nakamura K, Abe R, Matsushima A, Beppu M, Yamanaka Y, Takahashi Y, Sasaki H, Mizusawa H. Idiopathic cerebellar ataxia (IDCA): Diagnostic criteria and clinical analyses of 63 Japanese patients. J Neurol Sci. 2018;384:30-35.
  63. Yamamoto T, Uchiyama T, Asahina M, Yamanaka Y, Hirano S, Higuchi Y, Kuwabara S. Urinary symptoms are correlated with quality of life after deep brain stimulation in Parkinson's disease. Brain Behav. 2018;8(12):e01164.
  64. Zhao N, Liu C C, Van Ingelgom A J, Linares C, Kurti A, Knight J A, Heckman M G, Diehl N N, Shinohara M, Martens Y A, Attrebi O N, Petrucelli L, Fryer J D, Wszolek Z K, Graff-Radford N R, Caselli R J, Sanchez-Contreras M Y, Rademakers R, Murray M E, Koga S, Dickson D W, Ross O A Bu G. APOE epsilon2 is associated with increased tau pathology in primary tauopathy. Nat Commun. 2018;9(1):4388.

2017年（Total Impact Factor 365.021）総説7件　原書・短報76件

総説

  1. Kuwabara S, Misawa S, Mori M. Nodopathy: chronic inflammatory demyelinating polyneuropathy with anti-neurofascin 155 antibodies. J Neurol Neurosurg Psychiatry.2017;88(6):459.
  2. Kuwabara S, Sekiguchi Y, Misawa S. Electrophysiology in Fisher syndrome. Clin Neurophysiol. 2017;128(1):215-219.
  3. Kuwabara S, Uzawa A, Mori M. Neuroimmunology of a natural disaster. J Neurol Neurosurg Psychiatry. 2017;88(4):283.
  4. Mori M, Uzawa A, Kuwabara S. Geographical differences in preventative therapies for neuromyelitis optica spectrum disorder. J Neurol Neurosurg Psychiatry. 2017;88(8):620.
  5. Ogawa T, Sakakibara R, Kuno S, Ishizuka O, Kitta T, Yoshimura N. Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy. Nat Rev Urol. 2017;14(2):79-89.
  6. Sakakibara R. Editorial Comment from Dr Sakakibara to Case of possible multiple system atrophy with a characteristic imaging finding of open bladder neck during storage phase as an initial sign. Int J Urol. 2017;24(11):819-820.
  7. Uncini A, Shahrizaila N, Kuwabara S. Zika virus infection and Guillain-Barre syndrome: a review focused on clinical and electrophysiological subtypes. J Neurol Neurosurg Psychiatry. 2017;88(3):266-271.

原著・短報

  1. Aiba Y, Sakakibara R, Tsuyusaki Y, Kishi M, Tateno F, Ogata T, Nagao T, Terada H, Inaoka T. Anticoagulant-Free but Dangerous: Perisurgical Consideration. J Stroke Cerebrovasc Dis. 2017;26(9):2038-2040.
  2. Beppu M, Sawai S, Misawa S, Mori M, Ito S, Sogawa K, Nishimura M, Matsushita K, Nomura F, Kuwabara S. Serum cytokine and chemokine profiles in patients with juvenile muscular atrophy of distal upper extremity (Hirayama disease). J Neuroimmunol. 2017;302:20-22.
  3. Enokizono M, Sato N, Morikawa M, Kimura Y, Sugiyama A, Maekawa T, Sone D, Takewaki D, Okamoto T, Takahashi Y, Horie N, Matsuo T. "Black butterfly" sign on T2*-weighted and susceptibility-weighted imaging: A novel finding of chronic venous congestion of the brain stem and spinal cord associated with dural arteriovenous fistulas. J Neurol Sci.2017;379:64-68.
  4. Heckman M G, Kasanuki K, Diehl N N, Koga S, Soto A, Murray M E, Dickson D W, Ross O A. Parkinson's disease susceptibility variants and severity of Lewy body pathology. Parkinsonism Relat Disord. 2017;44:79-84.
  5. Higashi K, Shibasaki M, Kuni K, Uemura T, Waragai M, Uemura K, Igarashi K, Toida T. Determination of 3-hydroxypropylmercapturic acid in urine by three column-switching high-performance liquid chromatography with electrochemical detection using a diamond electrode. J Chromatogr A. 2017;1517:79-85.
  6. Hiraga A. Gender Differences and Stroke Outcomes. Neuroepidemiology. 2017;48(1-2):61-62.
  7. Hiraga A, Aotsuka Y, Koide K, Kuwabara S. Reversible cerebral vasoconstriction syndrome precipitated by airplane descent: Case report. Cephalalgia. 2017;37(11):1102-1105.
  8. Hiraga A, Kuwabara S. Malignant Syndrome and Serotonin Syndrome in a General Hospital Setting: Clinical Features, Frequency and Prognosis. Intern Med. 2017;56(21):2865-2869.
  9. Hiraga A, Kuwabara S. Headache attributed to aeroplane travel and reversible cerebral vasoconstriction syndrome. Cephalalgia. 2017;37(13):1310.
  10. Hiwasa T, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Kunimatsu M, Mine S, Machida T, Sato E, Takemoto M, Hattori A, Kobayashi K, Kawamura H, Ishibashi R, Yokote K, Kitamura K, Ohno M, Chen PM, Nishi E, Ono K, Kimura T, Takizawa H, Kashiwado K, Kamitsukasa I, Wada T, Aotsuka A, Sunami K, Kobayashi E, Yoshida Y, Matsutani T, Iwadate Y, Mori M, Uzawa A, Muto M, Sugimoto K, Kuwabara S, Iwata Y, Kobayashi Y, Terada J, Matsumura T, Sakao S, Tatsumi K, Ito M, Shimada H, Zhang XM, Kimura R, Wang H, Iwase K, Ashino H, Taira A, Arita E, Goto K, Kudo T, Doi H. Serum SH3BP5-specific antibody level is a biomarker of atherosclerosis. Immunome Res. 2017;13:132.
  11. Homma M, Uzawa A, Tanaka H, Kawaguchi N, Kanai T, Nakajima K, Narita M, Hara Y, Maruyama H, Ogawa Y, Himuro K, Kuwabara S. A Novel Fusion Protein, AChR-Fc, Ameliorates Myasthenia Gravis by Neutralizing Antiacetylcholine Receptor Antibodies and Suppressing Acetylcholine Receptor-Reactive B Cells. Neurotherapeutics. 2017;14(1):191-198.
  12. Horng S, Therattil A, Moyon S, Gordon A, Kim K, Argaw A T, Hara Y, Mariani J N, Sawai S, Flodby P, Crandall E D, Borok Z, Sofroniew M V, Chapouly C, John G R. Astrocytic tight junctions control inflammatory CNS lesion pathogenesis. J Clin Invest. 2017;127(8):3136-3151.
  13. Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol. 2017;16(12):976-986.
  14. Ito H, Kawaguchi H, Kodaka F, Takuwa H, Ikoma Y, Shimada H, Kimura Y, Seki C, Kubo H, Ishii S, Takano H, Suhara T. Normative data of dopaminergic neurotransmission functions in substantia nigra measured with MRI and PET: Neuromelanin, dopamine synthesis, dopamine transporters, and dopamine D2 receptors. Neuroimage. 2017;158:12-17.
  15. Kamagata K, Nakatsuka T, Sakakibara R, Tsuyusaki Y, Takamura T, Sato K, Suzuki M, Hori M, Kumamaru K K, Inaoka T, Aoki S, Terada H. Erratum to: Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study. Neuroradiology. 2017;59(4):425.
  16. Kamagata K, Nakatsuka T, Sakakibara R, Tsuyusaki Y, Takamura T, Sato K, Suzuki M, Hori M, Kumamaru K K, Inaoka T, Aoki S, Terada H. Diagnostic imaging of dementia with Lewy bodies by susceptibility-weighted imaging of nigrosomes versus striatal dopamine transporter single-photon emission computed tomography: a retrospective observational study. Neuroradiology. 2017;59(1):89-98.
  17. Kanai T, Uzawa A, Kawaguchi N, Himuro K, Oda F, Ozawa Y, Kuwabara S. Adequate tacrolimus concentration for myasthenia gravis treatment. Eur J Neurol. 2017;24(2):270-275.
  18. Kanai T, Uzawa A, Sato Y, Suzuki S, Kawaguchi N, Himuro K, Oda F, Ozawa Y, Nakahara J, Suzuki N, Takahashi Y K, Ishibashi S, Yokota T, Ogawa T, Yokoyama K, Hattori N, Izaki S, Oji S, Nomura K, Kaneko J, Nishiyama K, Yoshino I, Kuwabara S. A clinical predictive score for postoperative myasthenic crisis. Ann Neurol. 2017;82(5):841-849.
  19. Kasanuki K, Heckman M G, Diehl N N, Murray M E, Koga S, Soto A, Ross O A, Dickson D W. Regional analysis and genetic association of nigrostriatal degeneration in Lewy body disease. Mov Disord. 2017;32(11):1584-1593.
  20. Kishi M, Sakakibara R, Takahashi O, Nakamura H, Tateno F, Tsuyusaki Y, Aiba Y, Ogata T, Suzuki Y. Seiza-induced neuropathy: an occupational peroneal neuropathy in a Japanese lady. Neurol Sci. 2017;38(8):1521-1522.
  21. Koga S, Kasanuki K, Dickson D W. alpha-synuclein astrogliopathy: A possible specific feature in alpha-synucleinopathy. Neuropathology. 2017;37(4):379-381.
  22. Koga S, Ono M, Sahara N, Higuchi M, Dickson D W. Fluorescence and autoradiographic evaluation of tau PET ligand PBB3 to alpha-synuclein pathology. Mov Disord. 2017;32(6):884-892.
  23. Koga S, Parks A, Dickson D W. Reply re: "Profile of cognitive impairment and underlying pathology in multiple system atrophy". Mov Disord. 2017;32(9):1339-1340.
  24. Koga S, Parks A, Kasanuki K, Sanchez-Contreras M, Baker M C, Josephs K A, Ahlskog J E, Uitti R J, Graff-Radford N, van Gerpen J A, Wszolek Z K, Rademakers R, Dickson D W. Cognitive impairment in progressive supranuclear palsy is associated with tau burden. Mov Disord. 2017;32(12):1772-1779.
  25. Koga S, Parks A, Uitti R J, van Gerpen J A, Cheshire W P, Wszolek Z K, Dickson D W. Profile of cognitive impairment and underlying pathology in multiple system atrophy. Mov Disord. 2017;32(3):405-413.
  26. Koga S, Sanchez-Contreras M, Josephs K A, Uitti R J, Graff-Radford N, van Gerpen J A, Cheshire W P, Wszolek Z K, Rademakers R, Dickson D W. Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy. Mov Disord. 2017;32(2):246-255.
  27. Kuwabara S, Mori M, Misawa S, Suzuki M, Nishiyama K, Mutoh T, Doi S, Kokubun N, Kamijo M, Yoshikawa H, Abe K, Nishida Y, Okada K, Sekiguchi K, Sakamoto K, Kusunoki S, Sobue G, Kaji R. Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial. J Neurol Neurosurg Psychiatry. 2017;88(10):832-838.
  28. Laitman B M, Mariani J N, Zhang C, Sawai S, John G R. Karyopherin Alpha Proteins Regulate Oligodendrocyte Differentiation. PLoS One. 2017;12(1):e0170477.
  29. Makino T, Kamitsukasa I, Ito S. Reversible Cerebral Vasoconstriction Syndrome due to Atovaquone. Case Rep Neurol. 2017;9:304-308.
  30. Masuda H, Hirano S, Takahashi N, Hatsugano E, Uzawa A, Uchida T, Ohtani R, Kuwabara S, Mori M. Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder. PLoS One. 2017;12(8):e0184012.
  31. Masuda H, Mori M, Iwai Y, Kuwabara S. Severe Subcutaneous Calcification in an Interferon-beta-treated MS Patient. Intern Med. 2017;56(7):879-880.
  32. Masuda H, Mori M, Uchida T, Uzawa A, Ohtani R, Kuwabara S. Soluble CD40 ligand contributes to blood-brain barrier breakdown and central nervous system inflammation in multiple sclerosis and neuromyelitis optica spectrum disorder. J Neuroimmunol. 2017;305:102-107.
  33. Matsubara K, Ibaraki M, Shimada H, Ikoma Y, Suhara T, Kinoshita T, Ito H. Erratum to "Impact of spillover from white matter by partial volume effect on quantification of amyloid deposition with [11C]PiB PET" [NeuroImage 143 (2016) 316-324]. Neuroimage. 2017;153:411.
  34. Mishima T, Kasanuki K, Koga S, Castanedes-Casey M, Wszolek Z K, Tsuboi Y, Dickson D W. Reduced orexin immunoreactivity in Perry syndrome and multiple system atrophy. Parkinsonism Relat Disord. 2017;42:85-89.
  35. Mishima T, Koga S, Lin W L, Kasanuki K, Castanedes-Casey M, Wszolek Z K, Oh S J, Tsuboi Y, Dickson D W. Perry Syndrome: A Distinctive Type of TDP-43 Proteinopathy. J Neuropathol Exp Neurol. 2017;76(8):676-682.
  36. Moriguchi S, Takano H, Kimura Y, Nagashima T, Takahata K, Kubota M, Kitamura S, Ishii T, Ichise M, Zhang M R, Shimada H, Mimura M, Meyer J H, Higuchi M, Suhara T. Occupancy of Norepinephrine Transporter by Duloxetine in Human Brains Measured by Positron Emission Tomography with (S,S)-[18F]FMeNER-D2. Int J Neuropsychopharmacol. 2017;20(12):957-962.
  37. Munetsugu T, Fujimoto T, Oshima Y, Sano K, Murota H, Satoh T, Iwase S, Asahina M, Nakazato Y, Yokozeki H. Revised guideline for the diagnosis and treatment of acquired idiopathic generalized anhidrosis in Japan. J Dermatol. 2017;44(4):394-400.
  38. Munetsugu T, Fujimoto T, Satoh T, Nakazato Y, Ohshima Y, Asahina M, Yokozeki H. Evaluation of the correlation between severity of acquired idiopathic generalized anhidrosis and quality of life scores. J Dermatol. 2017;44(7):747-752.
  39. Murakawa M, Shibuya K, Sekiguchi Y, Kuwabara S. Pontine Syphilitic Gumma in an HIV-negative Patient. Intern Med. 2017;56(13):1747-1748.
  40. Muto M, Mori M, Liu J, Uzawa A, Uchida T, Masuda H, Ohtani R, Sugimoto K, Kuwabara S. Serum soluble Talin-1 levels are elevated in patients with multiple sclerosis, reflecting its disease activity. J Neuroimmunol. 2017;305:131-134.
  41. Muto T, Ohwada C, Takaishi K, Isshiki Y, Nagao Y, Hasegawa N, Kawajiri-Manako C, Togasaki E, Shimizu R, Tsukamoto S, Sakai S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Misawa S, Shimizu N, Iseki T, Kuwabara S, Nakaseko C. Safety and Efficacy of Granulocyte Colony-Stimulating Factor Monotherapy for Peripheral Blood Stem Cell Collection in POEMS Syndrome. Biol Blood Marrow Transplant. 2017;23(2):361-363.
  42. Nagane Y, Murai H, Imai T, Yamamoto D, Tsuda E, Minami N, Suzuki Y, Kanai T, Uzawa A, Kawaguchi N, Masuda M, Konno S, Suzuki H, Aoki M, Utsugisawa K. Social disadvantages associated with myasthenia gravis and its treatment: a multicentre cross-sectional study. BMJ Open. 2017;7(2):e013278.
  43. Nomura K, Kusunoki S, the Research Group of IfGBSiJ.  Japanese multicenter clinical trial of intravenous polyethylene glycol-treated immunoglobulin and comparison with previous clinical trial of sulfonated immunoglobulin in Guillain–Barré syndrome. Clinical and Experimental Neuroimmunology. 2017;8(3):258-66.
  44. Noto Y I, Shibuya K, Shahrizaila N, Huynh W, Matamala J M, Dharmadasa T, Kiernan M C. Detection of fasciculations in amyotrophic lateral sclerosis: The optimal ultrasound scan time. Muscle Nerve. 2017;56(6):1068-1071.
  45. Noto Y I, Simon N, Shibuya K, Matamala J M, Dharmadasa T, Kiernan M C. Dynamic muscle ultrasound identifies upper motor neuron involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(5-6):404-410.
  46. Omori S, Isose S, Misawa S, Watanabe K, Sekiguchi Y, Shibuya K, Beppu M, Amino H, Kuwabara S. Pain-related evoked potentials after intraepidermal electrical stimulation to Adelta and C fibers in patients with neuropathic pain. Neurosci Res. 2017;121:43-48.
  47. Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, Dickson D W, Trojanowski J Q, Lee V M, Yoshida M, Hozumi I, Yoshiyama Y, van Swieten J C, Nordberg A, Suhara T, Zhang M R, Higuchi M. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies. Brain. 2017;140(3):764-780.
  48. Nakamura R, Tomiyoshi G, Shinmen N, Kuroda H, Kudo T, Doi H, Mine S, Machida T, Kamitsukasa I, Wada T, Aotsuka A, Kobayashi E, Yoshida Y, Matsutani T, Iwadate Y, Mori M, Uzawa A, Muto M, Sugimoto K, Kuwabara K, Takemoto M, Hattori A, Kobayashi K, Kawamura H, Ishibashi R, Yokote K, Iwata Y, Harada J, Kobayashi Y, Terada J, Matsumura T, Sakao S, Tatsumi K, Ohno M, Chen P, Nishi E, Ono K, Kimura T, Kitamura K, Takizawa H, Kashiwado K, Shimada H, Ito M, Goto K, Zhang X, Kimura R, Wang H, Taira A, Arita E, Ashino H, Iwase K, Hiwasa T. An Anti-Deoxyhypusine Synthase Antibody as a Marker of AtherosclerosisRelated Cerebral Infarction, Myocardial Infarction, Diabetes Mellitus, and Chronic Kidney Disease. SM Atheroscler J. 2017;1(1):1001.
  49. Sakakibara R, Tateno F, Kishi M, Tsuyusaki Y, Aiba Y, Terada H, Inaoka T, Sawai S, Kuwabara S, Nomura F. Genetic Screening for Spinocerebellar Ataxia Genes in a Japanese Single-Hospital Cohort. J Mov Disord. 2017;10(3):116-122.
  50. Sano K, Asahina M, Uehara T, Matsumoto K, Araki N, Okuyama R. Degranulation and shrinkage of dark cells in eccrine glands and elevated serum carcinoembryonic antigen in patients with acquired idiopathic generalized anhidrosis. J Eur Acad Dermatol Venereol. 2017;31(12):2097-2103.
  51. Shahnawaz M, Tokuda T, Waragai M, Mendez N, Ishii R, Trenkwalder C, Mollenhauer B, Soto C. Development of a Biochemical Diagnosis of Parkinson Disease by Detection of alpha-Synuclein Misfolded Aggregates in Cerebrospinal Fluid. JAMA Neurol. 2017;74(2):163-172.
  52. Shahrizaila N, Noto Y, Simon N G, Huynh W, Shibuya K, Matamala J M, Dharmadasa T, Devenney E, Kennerson M L, Nicholson G A, Kiernan M C. Quantitative muscle ultrasound as a biomarker in Charcot-Marie-Tooth neuropathy. Clin Neurophysiol. 2017;128(1):227-232.
  53. Shibuya K, Park S B, Howells J, Huynh W, Noto Y I, Shahrizaila N, Matamala J M, Vucic S, Kiernan M C. Laterality of motor cortical function measured by transcranial magnetic stimulation threshold tracking. Muscle Nerve. 2017;55(3):424-427.
  54. Shibuya K, Simon N G, Geevasinga N, Menon P, Howells J, Park S B, Huynh W, Noto Y I, Vucic S, Kiernan M C. The evolution of motor cortical dysfunction in amyotrophic lateral sclerosis. Clin Neurophysiol. 2017;128(6):1075-1082.
  55. Shinohara M, Koga S, Konno T, Nix  Shinohara M, Aoki N, Das P, Parisi JE, Petersen RC, Rosenberry TL, Dickson DW, Bu G. Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-β42 in Alzheimer's disease. Brain. 2017;140(12):3301-3316.
  56. Sone D, Watanabe M, Ota M, Kimura Y, Sugiyama A, Maekawa T, Okura M7, Enokizono M, Imabayashi E, Sato N, Matsuda H. Thalamic hypoperfusion and disrupted cerebral blood flow networks in idiopathic generalized epilepsy: Arterial spin labeling and graph theoretical analysis. Epilepsy Res. 2017;129:95-100.
  57. Sugimoto K, Tomiyoshi G, Mori M, Kuwabara S, Hirano S, Sawai S, Beppu M, Muto M, Uzawa A, Kitamura K, Takemoto M, Hattori A, Yamamoto M, Kobayashi K, Kawamura H, Ishibashi R, Yokote K, Mine S, Machida T, Kobayashi E, Yoshida Y, Matsutani T, Iwadate Y, Kobayashi Y, Nakamura R, Shinmen N, Kuroda H, Wang H, Xiao-Meng Zhang, Hiwasa T. Identification of Serum Anti-GADD34 Antibody as a Common Marker of Diabetes Mellitus and Parkinson Disease. Journal of Alzheimers Disease & Parkinsonism. 2017;7(4).
  58. Sugiyama A, Kobayashi M, Daizo A, Suzuki M, Kawashima H, Kagami S. I, Tanaka H, Suzuki Y, Matsunaga T, Kuwabara S.　 Diffuse Cerebral Vasoconstriction in a Intravascular Lymphoma Patient with a High Serum MPO-ANCA Level. Intern Med. 2017;56(13):1715-1718.
  59. Sugiyama A, Sato N, Kimura Y, Maekawa T, Enokizono M, Saito Y, Takahashi Y, Matsuda H, Kuwabara S. MR Imaging Features of the Cerebellum in Adult-Onset Neuronal Intranuclear Inclusion Disease: 8 Cases. Am J Neuroradiol 2017;38(11):2100-2104.
  60. Sugiyama A, Sone D, Sato N, Kimura Y, Ota M, Maikusa N, Maekawa T, Enokizono M, Mori-Yoshimura M, Ohya Y, Kuwabara S, Matsuda H. Brain gray matter structural network in myotonic dystrophy type 1. PLoS One. 2017;12(11):e0187343.
  61. Sugiyama A, Sato N, Kimura Y, Maekawa T, Wakasugi N, Sone D, Enokizono M, Takahashi Y, Murata M, Mizusawa H, Matsuda H. Thalamic involvement determined using VSRAD advance on MRI and easy Z-score analysis of 99mTc-ECD-SPECT in Gerstmann-Sträussler-Scheinker syndrome with P102L mutation. J Neurol Sci. 2017;373:27-30.
  62. Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Kadowaki T, Hirata K. Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study. J Neurol Neurosurg Psychiatry. 2017;88(11):953-959.
  63. Suzuki K, Okuma Y, Uchiyama T, Miyamoto M, Sakakibara R, Shimo Y, Hattori N, Kuwabara S, Yamamoto T, Kaji Y, Hirano S, Numao A, Hirata K. Characterizing restless legs syndrome and leg motor restlessness in patients with Parkinson's disease: A multicenter case-controlled study. Parkinsonism Relat Disord. 2017;44:18-22.
  64. Suzuki S, Misawa S, Ota T, Li Y, Kuwabara S, Ikusaka M. Post-Polio-Like Syndrome. Am J Med. 2017;130(11):e491-e492.
  65. Tatebe H, Kasai T, Ohmichi T, Kishi Y, Kakeya T, Waragai M, Kondo M, Allsop D, Tokuda T. Quantification of plasma phosphorylated tau to use as a biomarker for brain Alzheimer pathology: pilot case-control studies including patients with Alzheimer's disease and down syndrome. Mol Neurodegener. 2017;12(1):63.
  66. Tsunoda K, Yamashita T, Shimada H, Nomura E, Takahashi Y, Shang J, Sato K, Takemoto M, Hishikawa N, Ohta Y, Higuchi M, Suhara T, Kokubo Y, Kuzuhara S, Abe K. A migration case of Kii amyotrophic lateral sclerosis/parkinsonism dementia complex with the shortest stay in the endemic area and the longest incubation to develop the disease. J Clin Neurosci. 2017;46:64-67.
  67. Uchida T, Mori M, Uzawa A, Masuda H, Muto M, Ohtani R, Kuwabara S. Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: Their possible role on blood-brain barrier disruption. Mult Scler. 2017;23(8):1072-1084.
  68. Uncini A, Ippoliti L, Shahrizaila N, Sekiguchi Y, Kuwabara S. Optimizing the electrodiagnostic accuracy in Guillain-Barre syndrome subtypes: Criteria sets and sparse linear discriminant analysis. Clin Neurophysiol. 2017;128(7):1176-1183.
  69. Utsugisawa K, Nagane Y, Akaishi T, Suzuki Y, Imai T, Tsuda E, Minami N, Uzawa A, Kawaguchi N, Masuda M, Konno S, Suzuki H, Murai H, Aoki M. Early fast-acting treatment strategy against generalized myasthenia gravis. Muscle Nerve. 2017;55(6):794-801.
  70. Uzawa A, Mori M, Masuda H, Ohtani R, Uchida T, Sawai S, Kuwabara S. Interleukin-6 analysis of 572 consecutive CSF samples from neurological disorders: A special focus on neuromyelitis optica. Clin Chim Acta. 2017 ;469:144-149.
  71. Waragai M, Moriya M, Nojo T. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study. J Alzheimers Dis. 2017;60(4):1411-1427.
  72. Yamagishi Y, Suzuki H, Sonoo M, Kuwabara S, Yokota T, Nomura K, Chiba A, Kaji R, Kanda T, Kaida K, Ikeda S I, Mutoh T, Yamasaki R, Takashima H, Matsui M, Nishiyama K, Sobue G, Kusunoki S. Markers for Guillain-Barre syndrome with poor prognosis: a multi-center study. J Peripher Nerv Syst. 2017;22(4):433-439.
  73. Yamamoto T, Asahina M, Yamanaka Y, Uchiyama T, Hirano S, Fuse M, Koga Y, Sakakibara R, Kuwabara S. Postvoid residual predicts the diagnosis of multiple system atrophy in Parkinsonian syndrome. J Neurol Sci. 2017;381:230-234.
  74. Yamamoto T, Asahina M, Yamanaka Y, Uchiyama T, Hirano S, Fuse M, Koga Y, Sakakibara R, Kuwabara S. The Utility of Post-Void Residual Volume versus Sphincter Electromyography to Distinguish between Multiple System Atrophy and Parkinson's Disease. PLoS One. 2017;12(1):e0169405.
  75. Yamamoto T, Uchiyama T, Higuchi Y, Asahina M, Hirano S, Yamanaka Y, Weibing L, Kuwabara S. Long term follow-up on quality of life and its relationship to motor and cognitive functions in Parkinson's disease after deep brain stimulation. J Neurol Sci. 2017;379:18-21.
  76. Yokouchi H, Baba T, Misawa S, Kitahashi M, Oshitari T, Kuwabara S, Yamamoto S. Changes in subfoveal choroidal thickness and reduction of serum levels of vascular endothelial growth factor in patients with POEMS syndrome. Br J Ophthalmol. 2017;101(6):786-790.

2016年 総説5件　原書・短報60件

総説

  1. Kuwabara S, Misawa S. Future treatment for Guillain–Barre syndrome. Clin Exp Neuroimmunol. 2016;7(4):320-323.
  2. Shahrizaila N, Sobue G, Kuwabara S, Kim SH, Birks C, Fan DS, Bae JS, Hu CJ, Gourie-Devi M, Noto Y, Shibuya K, Goh KJ, Kaji R, Tsai CP, Cui L, Talman P, Henderson RD, Vucic S, Kiernan MC. Amyotrophic lateral sclerosis and motor neuron syndromes in Asia. J Neurol Neurosurg Psychiatry. 2017 ;88(4):283.
  3. Noto Y, Shibuya K, Vucic S, Kiernan MC. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis. Expert Rev Neurother. 2016;16(10):1147-54.
  4. Sekiyama K, Takamatsu Y, Koike W, Waragai M, Takenouchi T, Sugama S, Hashimoto M. Insight into the Dissociation of Behavior from Histology in Synucleinopathies and in Related Neurodegenerative Diseases. J Alzheimers Dis. 2016 ;52(3):831-41.
  5. Takamatsu Y, Koike W, Takenouchi T, Sugama S, Wei J, Waragai M, Sekiyama K, Makoto H. Protection against neurodegenerative disease on Earth and in space. npj Microgravity 2016;2:16013.

原著・短報

  1. Aiba Y, Sakakibara R, Abe F, Higuchi T, Tokuyama W, Hiruta N, Tateno F, Tsuyusaki Y, Kishi M, Tateno H, Ogata T. Neuronal intranuclear inclusion disease with leukoencephalopathy and light motor-sensory and autonomic neuropathy diagnosed by skin biopsy. J Neurol Sci. 2016;368:263-5.
  2. Aiba Y, Iwakawa M, Sakakibara R, Tsuyusaki Y, Tateno F, Kishi M, Tateno H, Ogata T. Myasthenia Gravis Manifesting As Head Drop in an Elderly Adult with Parkinson's Disease. J Am Geriatr Soc. 2016 ;64(10):e120-e122.
  3. Akaishi T, Suzuki Y, Imai T, Tsuda E, Minami N, Nagane Y, Uzawa A, Kawaguchi N, Masuda M, Konno S, Suzuki H, Murai H, Aoki M, Utsugisawa K. Response to treatment of myasthenia gravis according to clinical subtype. BMC Neurol. 2016;16:225.
  4. Akiba R, Yokouchi H, Mori M, Oshitari T, Baba T, Sawai S, Kuwabara S, Yamamoto S. Retinal Morphology and Sensitivity Are Primarily Impaired in Eyes with Neuromyelitis Optica Spectrum Disorder (NMOSD). PLoS One. 2016;11(12):e0167473.
  5. Aotsuka Y, Uzawa A, Nishimura K, Kojima K, Yamaguchi M, Makino T, Nakamichi K, Saijo M, Kuwabara S. Progressive Multifocal Leukoencephalopathy Localized in the Cerebellum and Brainstem Associated with Idiopathic CD4+ T Lymphocytopenia. Intern Med. 2016;55(12):1645-7.
  6. Araki N, Misawa S, Shibuya K, Ota S, Oide T, Kawano A, Beppu M, Nakatani Y and Kuwabara S. POEMS syndrome and calciphylaxis: an unrecognized cause of abnormal small vessel calcification. Orphanet J Rare Dis. 2016;11:35.
  7. Gulimire Abulaiti, Sawai S, Satoh M, Yamada M, Yaguchi M, Sogawa K, Beppu M, Kazami T, Kado S, Matsushita K, Tsukamoto A, Inomata T, Arai K, Kodera Y, Kuwabara S and Nomura F. Proteome Analysis of the Cerebellum Tissue in Chronically Alcohol-Fed Rats. J Alcohol Drug Depend. 2016;4(5):1000249.
  8. Hayano Y, Takasu K, Koyama Y, Yamada M, Ogawa K, Minami K, Asaki T, Kitada K, Kuwabara S, Yamashita T. Dorsal horn interneuron-derived Netrin-4 contributes to spinal sensitization in chronic pain via Unc5B. J Exp Med. 2016 Dec 12;213(13):2949-2966.
  9. Hiraga A, Koide K, Aotsuka Y, Kuwabara S. Reversible cerebral vasoconstriction syndrome with transient splenial lesion after delivery. Intern Med. 2016;55(22):3357-3359.
  10. Kaminski HJ, Himuro K, Alshaikh J, Gong B, Cheng G, Kusner LL. Differential RNA Expression Profile of Skeletal Muscle Induced by Experimental Autoimmune Myasthenia Gravis in Rats. Front Physiol. 2016;7:524.
  11. Iwai Y, Shibuya K, Misawa S, Sekiguchi Y, Watanabe K, Amino H, Kuwabara S. Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis. PLoS One 2016;11(7):e0158596.
  12. Kanai T, Uzawa A, Kawaguchi N, Sakamaki T, Yoshiyama Y, Himuro K, Oda F, Kuwabara S. HLA-DRB1*14 and DQB1*05 are associated with Japanese anti-MuSK antibody-positive myasthenia gravis patients. J Neurol Sci. 2016;363:116-8.
  13. Koga S, Dickson DW, Bieniek KF. Chronic Traumatic Encephalopathy Pathology in Multiple System Atrophy. J Neuropathol Exp Neurol. 2016;75(10):963-970.
  14. Koga S, Keith A. Josephs, Ogaki K, Catherine Labbé, Ryan J. Uitti, Neill Graff-Radford, Jay A. van Gerpen, William P. Cheshire, Aoki N, Rosa Rademakers, Zbigniew K. Wszolek, Owen A. Ross, Dennis W. Dickson. Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C. Mov Disord. 2016;31(5):653-62.
  15. Labbé C, Heckman MG, Lorenzo-Betancor O, Murray ME, Ogaki K, Soto-Ortolaza AI, Walton RL, Fujioka S, Koga S, Uitti RJ, van Gerpen JA, Petersen RC, Graff-Radford NR, Younkin SG, Boeve BF, Cheshire WP Jr, Low PA, Sandroni P, Coon EA, Singer W, Wszolek ZK, Dickson DW, Ross OA. MAPT haplotype diversity in multiple system atrophy. Parkinsonism Relat Disord. 2016;30:40-5.
  16. Masuda H, Mori M, Hirano S, Uzawa A, Uchida T, Ohtani R, Takahashi N, Kuwabara S. Impaired cognitive function and grey matter volume in multiple sclerosis relative to neuromyelitis optica spectrum disorder. Multiple sclerosi journal. 2016;22(S3):767-768.
  17. Masuda H, Mori M, Uzawa A, Muto M, Uchida T, Otani R, Akiba R, Yokouchi H, Yamamoto S, Kuwabara S. Recovery from optic neuritis attack in neuromyelitis optica spectrum disorder and multiple sclerosis. J Neurol Sci. 2016;367:375-9.
  18. Masuda H. Congress report of the 31st Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Barcelona. Clin Exp Neuroimmunol. 2016;(7)1:91-93.
  19. Masuda H, Mori M, Araki N, Kuwabara S. Bilateral Foot Acrocyanosis in an Interferon-β-treated MS Patient. Intern Med. 2016;55(3):319.
  20. Masuda H, Mori M, Uzawa A, Muto M, Uchida T, Kuwabara S. Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica. Eur J Neurol. 2016;23(2):276-81.
  21. Misawa S, Sato Y, Katayama K, Nagashima K, Aoyagi R, Sekiguchi Y, Sobue G, Koike H, Yabe I, Sasaki H, Watanabe O, Takashima H, Nishizawa M, Kawachi I, Kusunoki S, Mitsui Y, Kikuchi S, Nakashima I, Ikeda S, Kohara N, Kanda T, Kira J, Hanaoka H, Kuwabara S, Japanese POEMS Syndrome for Thalidomide (J-POST) Trial Study Group. Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2016;15(11):1129-37.
  22. Muto T, Ohwada C, Sawai S, Beppu M, Tsukamoto S, Takeda Y, Mimura N, Takeuchi M, Sakaida E, Sogawa K, Misawa S, Shimizu N, Iseki T, Nomura F, Kuwabara S, Nakaseko C. Acutely deteriorated extravascular volume overload during peripheral blood stem cell mobilization in POEMS syndrome: A case series with cytokine analysis. Transfus Apher Sci. 2016;54(2):276-81.
  23. Nakamura H, Sakakibara R, Sugiyama M, Tateno F, Yano M, Takahashi O, Kishi M, Tsuyusaki Y, Tateno H, Aiba Y, Ogata T, Yamamoto T, Yamanishi T, Uchiyama T, Suzuki H, Tateno A, Suzuki Y. Neurologic diseases that cause female urinary retention. Bladder. 2016; 3: e20
  24. Nakamura R, Sone J, Atsuta N, Tohnai G, Watanabe H, Yokoi D, Nakatochi M, Watanabe H, Ito M, Senda J, Katsuno M, Tanaka F, Li Y, Izumi Y, Morita M, Taniguchi A, Kano O, Oda M, Kuwabara S, Abe K, Aiba I, Okamoto K, Mizoguchi K, Hasegawa K, Aoki M, Hattori N, Tsuji S, Nakashima K, Kaji R, Sobue G; Japanese Consortium for Amyotrophic Lateral Sclerosis Research (JaCALS). Next-generation sequencing of 28 ALS-related genes in a Japanese ALS cohort. Neurobiol Aging. 2016;39:219.e1-8.
  25. Nishimura K, Koga M, Minematsu K, Jun C. Takahashi, Nagatsuka K, Kobayashi J, Toyoda K. Intracerebral hemorrhage in patients after heart valve replacement. J Neurol Sci. 2016;363:195-9.
  26. Notturno F, Kokubun N, Sekiguki Y, Nagashima T, De Lauretis A, Yuki N, Kuwabara S, Uncini A. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes. J Neurol Sci. 2016;365:132-6.
  27. Nozaki H, Kato T, Nihonmatsu M, Saito Y, Mizuta I, Noda T, Koike R, Miyazaki K, Kaito M, Ito S, Makino M, Koyama A, Shiga A, Uemura M, Sekine Y, Murakami A, Moritani S, Hara K, Yokoseki A, Kuwano R, Endo N, Momotsu T, Yoshida M, Nishizawa M, Mizuno T, and Onodera O. Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL. Neurology. 2016;86(21):1964-74.
  28. Ogaki K, Koga S, Aoki N, Lin W, Suzuki K, Ross OA, Dickson DW. Adult-onset cerebello-brainstem dominant form of X-linked adrenoleukodystrophy presenting as multiple system atrophy: case report and literature review. Neuropathology. 2016;36(1):64-76.
  29. Ogata T, Sakakibara R, Tateno F, Tsuyusaki Y, Tateno H, Aiba Y, Kishi M, Inaoka T, Terada H, Doi H, Suzuki Y. Mild Cognitive Impairment as the Initial Manifestation of Progressive Supranuclear Palsy. J Am Geriatr Soc. 2016;64(3):683-5.
  30. Sakakibara R, Panicker J, Finazzi-Agro E, Iacovelli V, Bruschini H. Parkinson's Disease Subcomittee, The Neurourology Promotion Committee in The International Continence Society.  A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders. Neurourol Urodyn. 2016;35(5):551-63.
  31. Sakakibara R, Uchida Y, Ishii K, Hashimoto M, Ishikawa M, Kazui H, Yamamoto T, Uchiyama T, Tateno F, Kishi M, Tsuyusaki Y, Aiba Y, Tateno H, Nagao T, Terada H, Inaoka T; Members of SINPHONI (Study of Idiopathic Normal Pressure Hydrocephalus On Neurological Improvement). Bladder recovery relates with increased mid-cingulate perfusion after shunt surgery in idiopathic normal-pressure hydrocephalus: a single-photon emission tomography study. Int Urol Nephrol. 2016;48(2):169-74.
  32. Laitman BM, Asp L, Mariani JN, Zhang J, Liu J, Sawai S, Chapouly C, Horng S, Kramer EG, Mitiku N, Loo H, Burlant N, Pedre X, Hara Y, Nudelman G, Zaslavsky E, Lee YM, Braun DA, Lu QR, Narla G, Raine CS, Friedman SL, Casaccia P, John GR. The Transcriptional Activator Krüppel-like Factor-6 Is Required for CNS Myelination. PLoS Biol. 2016;14(5):e1002467.
  33. Ishiura H, Takahashi Y, Hayashi T, Saito K, Furuya H, Watanabe M, Murata M, Suzuki M, Sugiura A, Sawai S, Shibuya K, Ueda N, Ichikawa Y, Kanazawa I, Goto J, Tsuji S. Molecular epidemiology and clinical spectrum of hereditary spastic paraplegia in the Japanese population based on comprehensive mutational analyses. J Hum Genet. 2016;61(4):363-4.
  34. Ishige T, Nishimura M, Satoh M, Fujimoto M, Fukuyo M, Semba T, Kado S, Tsuchida S, Sawai S, Matsushita K, Togawa A, Matsubara H, Kaneda A, Nomura F. Combined Secretomics and Transcriptomics Revealed Cancer-Derived GDF15 is Involved in Diffuse-Type Gastric Cancer Progression and Fibroblast Activation. Scientific reports. 2016;6:21681.
  35. Drake MJ, Apostolidis A, Cocci A, Emmanuel A, Gajewski JB, Harrison SC, Heesakkers JP, Lemack GE, Madersbacher H, Panicker JN, Radziszewski P, Sakakibara R, Wyndaele JJ. Neurogenic lower urinary tract dysfunction: Clinical management recommendations of the Neurologic Incontinence committee of the fifth International Consultation on Incontinence 2013. Neurourol Urodyn. 2016;35(6):657-65.
  36. Sakakibara R, Panicker J, Finazzi-Agro E, Iacovelli V, Bruschini H; Parkinson's Disease Subcomittee, The Neurourology Promotion Committee in The International Continence Society. A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders. Neurourol Urodyn. 2016;35(5):551-63.
  37. Sekiguchi Y, Mori M, Misawa S, Sawai S, Yuki N, Beppu M, Kuwabara S. How often and when Fisher syndrome is overlapped by Guillain-Barré syndrome or Bickerstaff brainstem encephalitis? Eur J Neurol. 2016 ;23(6):1058-63.
  38. Shibuya K, Misawa S, Kimura H, Noto Y, Sekiguchi Y, Iwai Y, Shimizu T, Mizuno T, Nakagawa M, Kuwabara S. Increased motor axonal persistent sodium currents predict rapid functional declines in amyotrophic lateral sclerosis. Neurology and Clinical Neuroscience. 2016;4(3):108-11.
  39. Shibuya K, Susanna B. Park, Nimeshan Geevasinga, Parvathi Menon, James Howells, Neil G. Simon, William Huynh, Noto Y, Jürgen Götz, Jillian J Kril, Lars M Ittner, John Hodges, Glenda Halliday, Steve Vucic, and Matthew C. Kiernan. Motor cortical function determines prognosis in sporadic ALS. Neurology.　2016;87(5):513-20
  40. Shibuya K, Susanna B. Parka, Nimeshan Geevasingab, William Huynha, Neil G. Simona, Parvathi Menonb, James Howellsa, Steve Vucicb, Matthew C. Kiernana. Clin Neurophysiol. 2016;127(6):2355-61.
  41. Shimada H, Kitamura S, Shinotoh H, Endo H, Niwa F, Hirano S, Kimura Y, Zhang M R, Kuwabara S, Suhara T ,Higuchi M. Association between Abeta and tau accumulations and their influence on clinical features in aging and Alzheimer's disease spectrum brains: A [11C]PBB3-PET study. Alzheimers Dement (Amst). 2016;6:11-20.
  42. Sugiyama A, Kobayashi M, Moriishi H, Tanaka H, Mitsuyoshi R, Matsunaga T, Kuwabara S. Pneumocephalus associated with Pott’s puffy tumor. J Neurol Sci. 2016;362:196-7.
  43. Takahashi JC, Funaki T, Houkin K, Inoue T, Ogasawara K, Nakagawara J, Kuroda S, Yamada K, Miyamoto S; JAM Trial Investigators. Significance of the Hemorrhagic Site for Recurrent Bleeding: Prespecified Analysis in the Japan Adult Moyamoya Trial. Stroke. 2016;47(1):37-43.
  44. Tateno F, Sakakibara R, Aiba Y, Tsuyusaki Y, Kishi M, Tateno H, Ogata T. Stercoral Ulcer and Colonic Perforation in an Individual with Parkinson's Disease with Constipation. J Am Geriatr Soc. 2016 ;64(10):e118-e120.
  45. Tudor KI, Sakakibara R, Panicker JN. Neurogenic lower urinary tract dysfunction: evaluation and management. J Neurol. 2016;263(12):2555-2564.
  46. Tsuyusaki Y, Sakakibara R, Tateno F, Aiba Y, Kishi M, Tateno H, Ogata T, Inaoka T, Terada H, Suzuki Y. Multiple system atrophy presenting initially as spastic paraparesis. J Neurol Sci. 2016;360:176-8.
  47. Tsuyusaki Y, Sakakibara R, Ogata T, Tateno F, Kishi M, Tateno H, Aiba Y. Depth perception disorder after left ventral occipital lobe infarction. Neurocase. 2016;22(2):248-50.
  48. Uzawa A,Kanai T, Kawaguchi N, Oda F, Ozawa Y, Himuro K, Kuwabara, S. Relationship between damage-associated molecular pattern and cytokine levels in myasthenia gravis. Clin Exp Neuroimmunol. 2016;7(4):357-60.
  49. Uzawa A, Mori M, Uchida T, Masuda H, Ohtani R, Kuwabara S. Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria. Mult Scler. 2016;22(10):1371-5.
  50. Uzawa A, Kanai T, Kawaguchi N, Oda F, Himuro K, Kuwabara S. Changes in inflammatory cytokine networks in myasthenia gravis. Sci Rep. 2016;6:25886.
  51. Uzawa A, Mori M, Uchida T, Masuda H, Ohtani R, Kuwabara S. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis. Clin Chim Acta. 2016;453:131-3.
  52. Watanabe H, Atsuta N, Hirakawa A, Nakamura R, Nakatochi M, Ishigaki S, Iida A, Ikegawa S, Kubo M, Yokoi D, Watanabe H, Ito M, Katsuno M, Izumi Y, Morita M, Kanai K, Taniguchi A, Aiba I, Abe K, Mizoguchi K, Oda M, Kano O, Okamoto K, Kuwabara S, Hasegawa K, Imai T, Kawata A, Aoki M, Tsuji S, Nakashima K, Kaji R, Sobue G. A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of TTN. J Neurol Neurosurg Psychiatry. 2016;87(8):851-8.
  53. Waragai M, Adame A, Trinh I, Sekiyama K, Takamatsu Y, Une K, Masliah E, Hashimoto M. Possible Involvement of Adiponectin, the Anti-Diabetes Molecule, in the Pathogenesis of Alzheimer's Disease. J Alzheimers Dis. 2016;52(4):1453-9.
  54. Yamaguchi N, Misawa S, Sato Y, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kohara N, Hirata K, Nishiyama K, Yabe I, Kaida KI, Suzuki N, Nodera H, Tsuji S, Koike H, Kira JI, Hanaoka H, Kusunoki S, Kuwabara S. A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS). JMIR Res Protoc. 2016;5(4):e210.
  55. Yamamoto T, Tateno F, Sakakibara R, Furukawa S, Asahina M, Uchiyama T, Hirano S, Yamanaka Y, Fuse M, Koga Y, Yanagisawa M, Kuwabara S. Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders. PLoS One. 2016;11(2):e0149278.
  56. Yamamoto T, Mori M, Uzawa A, Uchiyama T, Sakakibara R, Yanagisawa M, and Kuwabara S. Urinary symptoms and neurological disabilities are differentially correlated between multiple sclerosis and neuromyelitis optica. Clin Exp Neuroimmunol.2016;7(1):52-58.
  57. Yamamoto T, Asahina M, Yamanaka Y, Uchiyama T, Hirano S, Sugiyama A, Sakakibara R, Kuwabara S. Urinary Dysfunctions Are More Severe in the Parkinsonian Phenotype of Multiple System Atrophy. Movement Disorders Clinical Practice　2016;3(3):275-281.
  58. Yano M, Sakakibara R, Tateno F, Takahashi O, Nakamura H, Sugiyama M, Fang-Ching L, Kamijima S, Kamiya N, Suzuki H. Urodynamic findings in patients with Creutzfeldt-Jakob disease: a case report. Int Urol Nephrol. 2016;48(10):1579-83.
  59. Yokoi D, Atsuta N, Watanabe H, Nakamura R, Hirakawa A, Ito M, Watanabe H, Katsuno M, Izumi Y, Morita M, Taniguchi A, Oda M, Abe K, Mizoguchi K, Kano O, Kuwabara S, Kaji R, Sobue G; JaCALS. Age of onset differentially influences the progression of regional dysfunction in sporadic amyotrophic lateral sclerosis. J Neurol. 2016;263(6):1129-36.
  60. Yokouchi H, Baba T, Misawa S, Sawai S, Kitahashi M, Oshitari T, Kuwabara S, Yamamoto S. Correlation between peripapillary retinal thickness and serum level of vascular endothelial growth factor in patients with POEMS syndrome. Br J Ophthalmol. 2016;100(7):897-901.